This inventor holds 1 USPTO granted patent. Top assignees: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Yeda Research and Develpment & Co. Ltd, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2011.
Company Filing History:
1 out of 60 
1 out of 1,168 
1 out of 911 
Years Active: 2011
Title: Dan Caspi: Innovator in Arthritis Treatment
Introduction
Dan Caspi is a notable inventor based in Rishon Lezion, Israel. He has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of arthritis and other chronic inflammatory diseases. His innovative work has led to the development of valuable patents that aim to improve patient outcomes.
Latest Patents
Dan Caspi holds a patent for "Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases." This patent includes isolated polynucleotides encoding novel galectin-8 variant polypeptides. The methods and kits provided in this patent are designed for diagnosing, prognosing, and treating rheumatoid arthritis (RA) and other joint and chronic inflammatory diseases.
Career Highlights
Throughout his career, Dan has worked with prominent organizations such as the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Dan has collaborated with notable colleagues, including Itshak Golan and Lora Melnik. These partnerships have further enhanced his research efforts and have played a crucial role in advancing his innovative projects.
Conclusion
Dan Caspi's work in the field of arthritis treatment exemplifies the impact of innovation in medical research. His patent and collaborations highlight his commitment to improving healthcare solutions for chronic inflammatory diseases. His contributions continue to pave the way for future advancements in this vital area of medicine.